Supplementary Figure 2 from Anti-HDGF Targets Cancer and Cancer Stromal Stem Cells Resistant to Chemotherapy

Jun Zhao,Mark Z. Ma,Hening Ren,Zhenqiu Liu,Martin J. Edelman,Hong Pan,Li Mao

DOI: https://doi.org/10.1158/1078-0432.22452492.v1

2023-01-01

Abstract:Supplementary Figure 2 - PDF file 693K, Notch intracellular domain IHC

What problem does this paper attempt to address?

Supplementary Figure Legends and Supplementary Figures 1 Through 4 from A Novel Therapeutic Strategy to Rescue the Immune Effector Function of Proteolytically Inactivated Cancer Therapeutic Antibodies

Xiaohui Fan,Randall J. Brezski,Hui Deng,Pooja Dhupkar,Yun Q. Shi,Anneliese Gonzalez,Songlin Zhang,Michael A. Rycyzyn,William R. Strohl,Robert E. Jordan,Ningyan Zhang,Zhiqiang An

DOI: https://doi.org/10.1158/1535-7163.22501711

2023-01-01

Abstract:Figure S1: IdeS expression in BT474 breast cancer cells Figure S2: Detection of MMPs in cancer cell lysates and culture supernatant Figure S3: scIgG-T was not in the SKBR-3 cell culture medium Figure S4: Detection of immune cells infiltration in mice by flow cytometry.
Supplementary Figure from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis

Jiahui Mou,Meijun Huang,Feifei Wang,Xiaoding Xu,Hanqi Xie,Henglei Lu,Mingyang Li,Yu Li,Weiwen Kong,Jing Chen,Ying Xiao,Yiding Chen,Chaochen Wang,Jin Ren

DOI: https://doi.org/10.1158/1541-7786.22527890

2023-01-01

Abstract:Supplementary Figure from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis
Supplementary Table 1 from BMP4 Administration Induces Differentiation of CD133+ Hepatic Cancer Stem Cells, Blocking Their Contributions to Hepatocellular Carcinoma

Lixing Zhang,Hefen Sun,Fangyu Zhao,Ping Lu,Chao Ge,Hong Li,Helei Hou,Mingxia Yan,Taoyang Chen,Guoping Jiang,Haiyang Xie,Ying Cui,Xiaowu Huang,Jia Fan,Ming Yao,Jinjun Li

DOI: https://doi.org/10.1158/0008-5472.22395144.v1

2023-01-01

Abstract:PDF file - 82K, Antibodies used in this study
Supplementary Figure 5 from CLIC4, ERp29, and Smac/DIABLO Derived from Metastatic Cancer Stem–like Cells Stratify Prognostic Risks of Colorectal Cancer

Yong-Jian Deng,Na Tang,Chao Liu,Jiang-Yu Zhang,Sheng-Li An,Yin-Li Peng,Li-Li Ma,Guang-Qiu Li,Qiang Jiang,Chun-Ting Hu,Ya-Nan Wang,Yao-Ze Liang,Xiu-Wu Bian,Wei-Gang Fang,Yan-Qing Ding

DOI: https://doi.org/10.1158/1078-0432.22445468.v1

2023-01-01

Abstract:PDF file - 2897K, Stemness of cancer stem-like cells related to ERp29, CLIC4 and Smac.
Supplementary Figure 2 from Targeting of Mir34a–notch1 Axis Reduced Breast Cancer Stemness and Chemoresistance

Eun Young Park,EunSun Chang,Eun Ji Lee,Hyun-Woo Lee,Hyeok-Gu Kang,Kyung-Hee Chun,Yu Mi Woo,Hyun Kyung Kong,Je Yeong Ko,Hiromu Suzuki,Erwei Song,Jong Hoon Park

DOI: https://doi.org/10.1158/0008-5472.22403298.v1

2023-01-01

Abstract:Supplementary Figure 2. Expression levels of Notch family in tumorsphere cells.
Supplementary Figure 2 from CLIC4, ERp29, and Smac/DIABLO Derived from Metastatic Cancer Stem–like Cells Stratify Prognostic Risks of Colorectal Cancer

Yong-Jian Deng,Na Tang,Chao Liu,Jiang-Yu Zhang,Sheng-Li An,Yin-Li Peng,Li-Li Ma,Guang-Qiu Li,Qiang Jiang,Chun-Ting Hu,Ya-Nan Wang,Yao-Ze Liang,Xiu-Wu Bian,Wei-Gang Fang,Yan-Qing Ding

DOI: https://doi.org/10.1158/1078-0432.22445477.v1

2023-01-01

Abstract:PDF file - 45K, Identifying cancer stem-like cells characteristics of tumor spheres.
Supplementary Figure 2 from Cancer Immunotherapy Using in Vitro Genetically Modified Targeted Dendritic Cells

Huafeng Wei,Hao Wang,Bing Lu,Bohua Li,Sheng Hou,Weizhu Qian,Kexing Fan,Jianxin Dai,Jian Zhao,Yajun Guo

DOI: https://doi.org/10.1158/0008-5472.22375074

2023-01-01

Abstract:Supplementary Figure 2 from Cancer Immunotherapy Using In vitro Genetically Modified Targeted Dendritic Cells
Supplementary Figure 5 from HER2-Associated Radioresistance of Breast Cancer Stem Cells Isolated from HER2-Negative Breast Cancer Cells

Nadire Duru,Ming Fan,Demet Candas,Cheikh Menaa,Hsin-Chen Liu,Danupon Nantajit,Yunfei Wen,Kai Xiao,Angela Eldridge,Brett A. Chromy,Shiyong Li,Douglas R. Spitz,Kit S. Lam,Max S. Wicha,Jian

DOI: https://doi.org/10.1158/1078-0432.22451723.v1

2023-01-01

Abstract:PDF file - 513K, IHS of co-activation of HER2/CD44 cells in tumor tissues
Supplementary Figure 1 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Guangcun Cheng,Xueqing Sun,Jinglong Wang,Gang Xiao,Xiumin Wang,Xuemei Fan,Lidong Zu,Mingang Hao,Qing Qu,Yan Mao,Yunjing Xue,Jianhua Wang

DOI: https://doi.org/10.1158/0008-5472.22401690

2023-01-01

Abstract:PDF file - 623K, Effects of restoring HIC1 expression in MDA-468 cells.
Supplementary Figure 2 from the Pivotal Role of Integrin Β1 in Metastasis of Head and Neck Squamous Cell Carcinoma

Dongsheng Wang,Susan Müller,A.R.M. Ruhul Amin,Donghai Huang,Ling Su,Zhongliang Hu,Mohammad Aminur Rahman,Sreenivas Nannapaneni,Lydia Koenig,Zhengjia Chen,Mourad Tighiouart,Dong M. Shin,Zhuo G. Chen

DOI: https://doi.org/10.1158/1078-0432.22447182

2023-01-01

Abstract:PDF file, 359K, OS and DFS analysis of chemotherapy on all patients.
Supplementary Figure 3 from HER2-Associated Radioresistance of Breast Cancer Stem Cells Isolated from HER2-Negative Breast Cancer Cells

Nadire Duru,Ming Fan,Demet Candas,Cheikh Menaa,Hsin-Chen Liu,Danupon Nantajit,Yunfei Wen,Kai Xiao,Angela Eldridge,Brett A. Chromy,Shiyong Li,Douglas R. Spitz,Kit S. Lam,Max S. Wicha,Jian

DOI: https://doi.org/10.1158/1078-0432.22451729

2023-01-01

Abstract:PDF file - 144K, FACS of irradiated MCF7 cells and xenograft tumors
Supplementary Figure 7 from CLIC4, ERp29, and Smac/DIABLO Derived from Metastatic Cancer Stem–like Cells Stratify Prognostic Risks of Colorectal Cancer

Yong-Jian Deng,Na Tang,Chao Liu,Jiang-Yu Zhang,Sheng-Li An,Yin-Li Peng,Li-Li Ma,Guang-Qiu Li,Qiang Jiang,Chun-Ting Hu,Ya-Nan Wang,Yao-Ze Liang,Xiu-Wu Bian,Wei-Gang Fang,Yan-Qing Ding

DOI: https://doi.org/10.1158/1078-0432.22445462

2023-01-01

Abstract:PDF file - 45K, Representative images of IHC examination of CLIC4, ERp29 and Smac in CRC tumors and mucosa.
Supplementary Figure 3 from CLIC4, ERp29, and Smac/DIABLO Derived from Metastatic Cancer Stem–like Cells Stratify Prognostic Risks of Colorectal Cancer

Yong-Jian Deng,Na Tang,Chao Liu,Jiang-Yu Zhang,Sheng-Li An,Yin-Li Peng,Li-Li Ma,Guang-Qiu Li,Qiang Jiang,Chun-Ting Hu,Ya-Nan Wang,Yao-Ze Liang,Xiu-Wu Bian,Wei-Gang Fang,Yan-Qing Ding

DOI: https://doi.org/10.1158/1078-0432.22445474.v1

2023-01-01

Abstract:PDF file - 41K, Comparison of tumor spheres metastatic potentials, invasive ability and EMT property.
Supplementary Figure 2 from Combination of Anti-HER3 Antibody MM-121/SAR256212 and Cetuximab Inhibits Tumor Growth in Preclinical Models of Head and Neck Squamous Cell Carcinoma

Ning Jiang,Dongsheng Wang,Zhongliang Hu,Hyung Ju C. Shin,Guoqing Qian,Mohammad Aminur Rahman,Hongzheng Zhang,A.R.M. Ruhul Amin,Sreenivas Nannapaneni,Xiaojing Wang,Zhengjia Chen,Gabriela Garcia,Gavin MacBeath,Dong M. Shin,Fadlo R. Khuri,Jun Ma,Zhuo G. Chen,Nabil F. Saba

DOI: https://doi.org/10.1158/1535-7163.22501338

2023-01-01

Abstract:PDF file - 255KB, Western blot analyses of HNSCC cell lines.
Supplementary Figure 2 from the Antitumor Activity of Homoharringtonine Against Human Mast Cells Harboring the KIT D816V Mutation

Yanli Jin,Zhongzheng Lu,Kaiyuan Cao,Yunhui Zhu,Qi Chen,Feng Zhu,Chenchen Qian,Jingxuan Pan

DOI: https://doi.org/10.1158/1535-7163.22485917.v1

2023-01-01

Abstract:Supplementary Figure 2 from The Antitumor Activity of Homoharringtonine against Human Mast Cells Harboring the KIT D816V Mutation
Supplementary Figure 2 from HER2-Associated Radioresistance of Breast Cancer Stem Cells Isolated from HER2-Negative Breast Cancer Cells

Nadire Duru,Ming Fan,Demet Candas,Cheikh Menaa,Hsin-Chen Liu,Danupon Nantajit,Yunfei Wen,Kai Xiao,Angela Eldridge,Brett A. Chromy,Shiyong Li,Douglas R. Spitz,Kit S. Lam,Max S. Wicha,Jian

DOI: https://doi.org/10.1158/1078-0432.22451732

2023-01-01

Abstract:PDF file - 36K, Mitochondrial membrane potential in HER2 siRNA treated cells
Supplementary Figure 5 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Guangcun Cheng,Xueqing Sun,Jinglong Wang,Gang Xiao,Xiumin Wang,Xuemei Fan,Lidong Zu,Mingang Hao,Qing Qu,Yan Mao,Yunjing Xue,Jianhua Wang

DOI: https://doi.org/10.1158/0008-5472.22401678

2023-01-01

Abstract:PDF file - 570K, LCN2 promotes lung metastasis in balb/c nude mice.
Supplementary Figures 1-2, Table 1 from Cancer Stem Cell Vaccination Confers Significant Antitumor Immunity

Ning Ning,Qin Pan,Fang Zheng,Seagal Teitz-Tennenbaum,Martin Egenti,Ji Yet,Mu Li,Christophe Ginestier,Max S. Wicha,Jeffrey S. Moyer,Mark E.P. Prince,Yingxin Xu,Xiao-Lian Zhang,Shiang Huang,Alfred E. Chang,Qiao Li

DOI: https://doi.org/10.1158/0008-5472.22395254.v1

2023-01-01

Abstract:PDF file - 185K
Supplementary Figure 5 from Inhibition of Protein Phosphatase 2A Radiosensitizes Pancreatic Cancers by Modulating CDC25C/CDK1 and Homologous Recombination Repair

Dongping Wei,Leslie A. Parsels,David Karnak,Mary A. Davis,Joshua D. Parsels,Amanda C. Marsh,Lili Zhao,Jonathan Maybaum,Theodore S. Lawrence,Yi Sun,Meredith A. Morgan

DOI: https://doi.org/10.1158/1078-0432.22450100

2023-01-01

Abstract:PDF file - 52K, LB100 causes an increase in pHistone H3 positive cells.
Supplementary Figure 1 from <i>Fra-1</i> Promotes Breast Cancer Chemosensitivity by Driving Cancer Stem Cells from Dormancy

Dan Lu,Si Chen,Xiaoyue Tan,Na Li,Chenghu Liu,Zongjin Li,Ze Liu,Dwayne G. Stupack,Ralph A. Reisfeld,Rong Xiang

DOI: https://doi.org/10.1158/0008-5472.22393310.v1

2023-01-01

Abstract:<p>PDF file - 2.1MB, Human breast cancer cells were treated with CTX (500uM) for 24hrs and the apoptosis were evaluated by Annexin V and PI double staining (A). Fra-1 expression in these breast cancer cells were detected by Western-blot (B)</p>

Supplementary Figure 2 from Anti-HDGF Targets Cancer and Cancer Stromal Stem Cells Resistant to Chemotherapy

Supplementary Figure Legends and Supplementary Figures 1 Through 4 from A Novel Therapeutic Strategy to Rescue the Immune Effector Function of Proteolytically Inactivated Cancer Therapeutic Antibodies

Supplementary Figure from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis

Supplementary Table 1 from BMP4 Administration Induces Differentiation of CD133+ Hepatic Cancer Stem Cells, Blocking Their Contributions to Hepatocellular Carcinoma

Supplementary Figure 5 from CLIC4, ERp29, and Smac/DIABLO Derived from Metastatic Cancer Stem–like Cells Stratify Prognostic Risks of Colorectal Cancer

Supplementary Figure 2 from Targeting of Mir34a–notch1 Axis Reduced Breast Cancer Stemness and Chemoresistance

Supplementary Figure 2 from CLIC4, ERp29, and Smac/DIABLO Derived from Metastatic Cancer Stem–like Cells Stratify Prognostic Risks of Colorectal Cancer

Supplementary Figure 2 from Cancer Immunotherapy Using in Vitro Genetically Modified Targeted Dendritic Cells

Supplementary Figure 5 from HER2-Associated Radioresistance of Breast Cancer Stem Cells Isolated from HER2-Negative Breast Cancer Cells

Supplementary Figure 1 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Supplementary Figure 2 from the Pivotal Role of Integrin Β1 in Metastasis of Head and Neck Squamous Cell Carcinoma

Supplementary Figure 3 from HER2-Associated Radioresistance of Breast Cancer Stem Cells Isolated from HER2-Negative Breast Cancer Cells

Supplementary Figure 7 from CLIC4, ERp29, and Smac/DIABLO Derived from Metastatic Cancer Stem–like Cells Stratify Prognostic Risks of Colorectal Cancer

Supplementary Figure 3 from CLIC4, ERp29, and Smac/DIABLO Derived from Metastatic Cancer Stem–like Cells Stratify Prognostic Risks of Colorectal Cancer

Supplementary Figure 2 from Combination of Anti-HER3 Antibody MM-121/SAR256212 and Cetuximab Inhibits Tumor Growth in Preclinical Models of Head and Neck Squamous Cell Carcinoma

Supplementary Figure 2 from the Antitumor Activity of Homoharringtonine Against Human Mast Cells Harboring the KIT D816V Mutation

Supplementary Figure 2 from HER2-Associated Radioresistance of Breast Cancer Stem Cells Isolated from HER2-Negative Breast Cancer Cells

Supplementary Figure 5 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Supplementary Figures 1-2, Table 1 from Cancer Stem Cell Vaccination Confers Significant Antitumor Immunity

Supplementary Figure 5 from Inhibition of Protein Phosphatase 2A Radiosensitizes Pancreatic Cancers by Modulating CDC25C/CDK1 and Homologous Recombination Repair

Supplementary Figure 1 from &lt;i&gt;Fra-1&lt;/i&gt; Promotes Breast Cancer Chemosensitivity by Driving Cancer Stem Cells from Dormancy

Supplementary Figure 1 from <i>Fra-1</i> Promotes Breast Cancer Chemosensitivity by Driving Cancer Stem Cells from Dormancy